Improving patient acceptance and adherence in diabetes management: A focus on insulin therapy

Advances in Therapy

Volumn 26, Issue 9, 2009, Pages 838-846

  Rakel, Robert E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Acceptance; Adherence; Insulin; Insulin pen; Primary care physician; Type 2 diabetes

Indexed keywords

INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN;

DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INJECTION SITE REACTION; INSULIN PUMP; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICIAN ATTITUDE; POSTPRANDIAL STATE; REVIEW; SELF MONITORING; SIDE EFFECT; THERAPY DELAY; WEIGHT GAIN;

BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE;

EID: 76749109340     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-009-0061-2     Document Type: Review

References (40)

1. D.M. Nathan 2002 Clinical practice. Initial management of glycemia in type 2 diabetes mellitus N Engl J Med 347 1342 1349 10.1056/NEJMcp021106 12397193 (Pubitemid 35215326)
2. J.B. Saaddine B. Cadwell E.W. Gregg 2006 Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002 Ann Intern Med 144 465 474 16585660
3. American Association of Clinical Endocrinologists. State of Diabetes in America. Available at: http://www.aace.com/public/awareness/stateofdiabetes/ DiabetesAmericaReport.pdf. Accessed August 5, 2009.
4. D.M. Nathan J.B. Buse M.B. Davidson 2009 Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 193 203 10.2337/dc08-9025 1:CAS:528:DC%2BD1MXhs1Gns78%3D 18945920
5. R.C. Turner C.A. Cull V. Frighi R.R. Holman 1999 Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA 281 2005 2012 10.1001/jama.281.21.2005 1:CAS:528:DyaK1MXjvFOls7g%3D 10359389 (Pubitemid 29254858)
6. J.B. Brown G.A. Nichols A. Perry 2004 The burden of treatment failure in type 2 diabetes Diabetes Care 27 1535 1540 10.2337/diacare.27.7.1535 15220224 (Pubitemid 38857422)
7. M. Peyrot R.R. Rubin T. Lauritzen 2005 Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study Diabetes Care 28 2673 2679 10.2337/diacare.28.11. 2673 16249538 (Pubitemid 43951158)
8. UK Prospective Diabetes Study Group. 1995 United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years BMJ 310 83 88
9. W.H. Polonsky L. Fisher S. Guzman L. Villa-Caballero S.V. Edelman 2005 Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem Diabetes Care 28 2543 2545 10.2337/diacare.28.10.2543 16186296 (Pubitemid 41384310)
10. S. Nakar G. Yitzhaki R. Rosenberg S. Vinker 2007 Transition to insulin in type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers J Diabetes Complications 21 220 226 10.1016/j.jdiacomp.2006.02.004 17616351 (Pubitemid 47002315)
11. J. Tibaldi R.E. Rakel 2007 Why, when and how to initiate insulin therapy in patients with type 2 diabetes Int J Clin Pract 61 633 644 10.1111/j.1742-1241.2007.01309.x 1:CAS:528:DC%2BD2sXlt1Kqs7k%3D 17394436 (Pubitemid 46449825)
12. E. Fleury-Milfort 2008 Practical strategies to improve treatment of type 2 diabetes J Am Acad Nurse Pract 20 295 304 10.1111/j.1745-7599.2008.00323.x 18588656
13. R.E. Rakel M.A. Weiss 2007 Diabetes care: are we asking the right questions Consultant 47 549 551
14. I.B. Hirsch 2005 Insulin analogues N Engl J Med 352 174 183 10.1056/NEJMra040832 1:CAS:528:DC%2BD2MXksFaitw%3D%3D 15647580 (Pubitemid 40096614)
15. M. Vazquez-Carrera J.S. Silvestre 2004 Insulin analogues in the management of diabetes Methods Find Exp Clin Pharmacol 26 445 461 1:CAS:528:DC%2BD2cXnsVKhsrg%3D 15349139
16. L. Monnier H. Lapinski C. Colette 2003 Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c) Diabetes Care 26 881 885 10.2337/diacare.26.3.881 12610053 (Pubitemid 36929359)
17. D.E. DeWitt I.B. Hirsch 2003 Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review JAMA 289 2254 2264 10.1001/jama.289.17.2265 1:CAS:528:DC%2BD3sXjsFalurk%3D 12734137 (Pubitemid 37430195)
18. M.C. Riddle J. Rosenstock J. Gerich 2003 The treat-totarget trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diabetes Care 26 3080 3086 10.2337/diacare.26.11.3080 1:CAS:528:DC%2BD3sXpsFert70%3D 14578243 (Pubitemid 37339502)
19. K. Hermansen M. Davies T. Derezinski G.M. Ravn P. Clauson P. Home 2006 A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes Diabetes Care 29 1269 1274 10.2337/dc05-1365 1:CAS:528:DC%2BD28XmtFKlsr4%3D 16732007 (Pubitemid 44125921)
20. T. Haak A. Tiengo E. Draeger M. Suntum W. Waldhausl 2005 Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes Diabetes Obes Metab 7 56 64 10.1111/j.1463-1326.2004.00373.x 1:CAS:528:DC%2BD2MXhsFGhtLk%3D 15642076
21. J. Rosenstock M. Davies P.D. Home J. Larsen C. Koenen G. Schernthaner 2008 A randomised, 52-week, treatto-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes Diabetologia 51 408 416 10.1007/s00125-007-0911-x 1:CAS:528:DC%2BD1cXhtlyls7c%3D 18204830
22. A. Dornhorst H.J. Luddeke S. Sreenan 2008 Insulin detemir improves glycaemic control without weight gain in insulin-naive patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study Int J Clin Pract 62 659 665 10.1111/j.1742-1241.2008.01715.x 1:STN:280:DC%2BD1c3jvFGjtw%3D%3D 18324957 (Pubitemid 351348041)
23. A. Dornhorst H.J. Luddeke S. Sreenan 2007 Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort Int J Clin Pract 61 523 528 10.1111/j.1742-1241.2007.01316.x 1:CAS:528:DC%2BD2sXmtFKhtrk%3D 17313628 (Pubitemid 46271267)
24. S.A. Schreiber T. Haak 2007 Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients Diabetes Obes Metab 9 31 38 10.1111/j.1463-1326.2006.00593.x 1:CAS:528:DC%2BD2sXitlCgsLs%3D 17199716 (Pubitemid 44921039)
25. J.L. Selam C. Koenen W. Weng L. Meneghini 2008 Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naive patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study Curr Med Res Opin 24 11 20 1:CAS:528:DC%2BD1cXhvVOgt74%3D 18021495 (Pubitemid 351160234)
26. R.L. Brunelle J. Llewelyn J.H. Anderson Jr. E.A. Gale V.A. Koivisto 1998 Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes Diabetes Care 21 1726 1731 10.2337/diacare.21.10.1726 1:STN:280:DyaK1cvksVOhsA%3D%3D 9773738 (Pubitemid 28449815)
27. A.R. Rolla R.E. Rakel 2005 Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues Clin Ther 27 1113 1125 10.1016/j.clinthera.2005.07.003 1:CAS:528:DC%2BD2MXhtFWgurnK 16199240 (Pubitemid 41393909)
28. J. Davidson P. Vexiau D. Cucinotta J. Vaz R. Kawamori 2005 Biphasic insulin aspart 30: literature review of adverse events associated with treatment Clin Ther 27 suppl.B S75 S88 10.1016/j.clinthera.2005.11.022 1:CAS:528:DC%2BD28XntlWntw%3D%3D 16519039
29. P. Roach M. Trautmann V. Arora B. Sun J.H. Anderson Jr. Mix50 Study Group 1999 Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin-protamine formulations, insulin lispro Mix25 Clin Ther 21 523 534 10.1016/S0149-2918(00)88307-1 1:CAS:528:DyaK1MXivF2hs78%3D 10321421 (Pubitemid 29198040)
30. R. Qayyum S. Bolen N. Maruthur 2008 Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes Ann Intern Med 149 549 559 18794553
31. A. Liebl R. Prager K. Binz M. Kaiser R. Bergenstal B. Gallwitz 2009 Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial Diabetes Obes Metab 11 45 52 10.1111/j.1463-1326.2008.00915.x 1:CAS:528:DC%2BD1MXhvVKrsLo%3D 18643839
32. A. Marcus 2008 Diabetes care-insulin delivery in a changing world Medscape J Med 10 120 18596953
33. S. Brunton 2008 Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment Am J Med 121 S35 S41 10.1016/j.amjmed.2008.03.025 1:CAS:528:DC%2BD1cXosFGmt7g%3D 18514089 (Pubitemid 351726337)
34. M. Korytkowski L. Niskanen T. Asakura 2005 FlexPen®: addressing issues of confidence and convenience in insulin delivery Clin Ther 27 suppl.B S89 100 10.1016/j.clinthera.2005.11.019 16519040
35. M. Korytkowski D. Bell C. Jacobsen R. Suwannasari 2003 A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus Clin Ther 25 2836 2848 10.1016/S0149-2918(03)80337-5 1:CAS:528:DC%2BD2cXhtVyntg%3D%3D 14693308 (Pubitemid 37510593)
36. J. Meece 2008 Effect of insulin pen devices on the management of diabetes mellitus Am J Health Syst Pharm 65 1076 1082 10.2146/ajhp070524 1:CAS:528:DC%2BD1cXnsFGiuro%3D 18499883 (Pubitemid 351768744)
37. C. Coscelli S. Lostia M. Lunetta I. Nosari G.A. Coronel 1995 Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old Diabetes Res Clin Pract 28 173 177 10.1016/0168-8227(95)01092-R 1:STN:280:DyaK287gsFGruw%3D%3D 8529495
38. M.R. Graff M.A. McClanahan 1998 Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe Clin Ther 20 486 496 10.1016/S0149-2918(98)80058-1 1:STN:280:DyaK1czislyqtg%3D%3D 9663364 (Pubitemid 28343501)
39. L. Meneghini C. Koenen W. Weng J.L. Selam 2007 The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes - results of the randomized, controlled PREDICTIVE™ 303 study Diabetes Obes Metab 9 902 913 10.1111/j.1463-1326.2007.00804.x 1:CAS:528:DC%2BD2sXhtlOlsLjI 17924873 (Pubitemid 47555212)
40. M. Davies F. Storms S. Shutler M. Bianchi-Biscay R. Gomis 2005 Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine Diabetes Care 28 1282 1288 10.2337/diacare.28.6.1282 1:CAS:528:DC%2BD2MXlsFyht7s%3D 15920040 (Pubitemid 40756686)